Navigation Links
9 Wiley authors win Nobel Prizes
Date:10/17/2007

Hoboken, N.J., October 17, 2007John Wiley & Sons, Inc, (NYSE:JWa) (NYSE:JWb), today announced that Nobel laureates in Chemistry, Physics, Economics, and Medicine are Wiley authors.

Congratulations to Dr. Gerhard Ertl, Dr. Mario R. Capecchi, Sir Martin Evans, Dr. Albert Fert, Dr. Peter Grnberg, Leonid Hurwicz, Dr. Erik Maskin, Dr. Roger Myerson, and Dr. Oliver Smithies on this recognition of their great achievements. We are honored and proud that they are members of Wileys author community, along with more than 350 other Nobel laureates who have published with us. Collaborating with this esteemed group of Nobel laureates reflects Wileys unwavering commitment to publishing cutting-edge research and sharing it with readers around the world, said William J. Pesce, Wiley's President and Chief Executive Officer.

Dr. Gerhard Ertl, of Germany, has received the Nobel Prize in Chemistry for his studies of chemical processes on solid surfaces. Dr. Ertl is co-editor of the eight-volume Handbook of Heterogeneous Catalysis, to appear in early 2008, and serves on the editorial boards of Chemistry A European Journal and ChemPhysChem, which are published by Wiley-VCH together with numerous European Chemical Societies.

Leonid Hurwicz, Dr. Erik Maskin, and Dr. Roger Myerson, all of the USA, were awarded the Nobel Prize in Economics for laying the foundations of mechanism design theory. All three Nobel laureates write for a variety of Wiley-Blackwell journals.

Dr. Peter Grnberg, of Germany, and Dr. Albert Fert, of France, were jointly awarded the Nobel Prize in Physics for the discovery of Giant Magnetoresistance. Dr. Grnberg recently published a highly-cited review article in the Physik Journal, on behalf of Germanys Physical Society, the worlds largest physical society. With his colleagues, Dr. Fert has coauthored several articles that appear in Wiley-Blackwell journals.

Dr. Mario R. Capecchi of the USA, Sir Martin Evans of the UK, and Dr. Oli
'/>"/>

Contact: Susan Spilka
sspilka@wiley.com
201-748-6147
Blackwell Publishing Ltd.
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Publishers John Wiley & Sons Enter Into An Agreement With NASPGHAN And AASLD
2. Dr. Scott Hammer Authors Two New Guidelines for HIV Treatment
3. Authors Review Astrodome Medical Response to Hurricane Katrina
4. Fast-Multiplying Lawsuits Can Stymie Medical Science, Authors Warn
5. Nobel Prize for Medicine shared by Three scientists
6. Stem cell research- now Nobel Laureates join the debate
7. Nobel laureates in chemistry
8. Nobel Prize for Medicine
9. Cholesterol Mystery Solved By Nobel Laureates
10. Nobel For Ulcer-Defying Aussie Scientists
11. Aussie Nobel Prize Winners Receive Their Awards
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2009)... and myeloproliferative disorders are serious and often deadly ... Annual Meeting of the American Society of Hematology ... methods for patients suffering from acute promyelocytic leukemia, ... myelofibrosis that are based on a better understanding ...
(Date:12/5/2009)... innovative new international private medical insurance plan which follows the acclaimed ... the flexibility to add or remove a wide range of options ... tailor their benefits to complement those already offered in their country ... ...
(Date:12/4/2009)... Investment Trust Inc. (NYSE: CRE ) ("Care" or ... a dividend of $0.17 per share of common stock. The ... record on December 14, 2009. ,, About ... real estate investment and finance company investing in healthcare-related real estate ...
(Date:12/4/2009)... Association of Homes and Services for the Aging (AAHSA) applauds ... Supportive Services (CLASS) provisions remain in the final health reform ... to elders, people with disabilities and their caregivers. ,, ... bill that will make it affordable to care for families ...
(Date:12/4/2009)... Bowen, Chief Information Officer at Crescent Healthcare, was selected ... Award for transforming Crescent,s business with the power of ... their innovative usage of Salesforce CRM or the Force.com ... their sales, marketing, partner, service, support or IT organizations. ...
Breaking Medicine News(10 mins):Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 2Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 3Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 4Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 5Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 6Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 7Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 8Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 9Health News:AVIVA's Private Health Insurance Products Solutions Go International 2Health News:Care Investment Trust Inc. Declares Quarterly Dividend of $0.17 Per Share 2Health News:Crescent CIO '09 Dreamforce Conference Speaker and Award Finalist 2
... have been accomplished by people who have kept on trying when ... Carnegie ,A groundbreaking venture has ... in cancer-treatment, are mass-produced in the egg white of a certain ... is one of the leading causes of death in the ...
... known as microchimerism has been known for some years, that ... pregnancy, and that these may live on for many// years, ... still unclear as to whether the presence of such cells ... team has looked for maternal cells in children with type ...
... point to yet another benefit of statins; improving survival in ... heart patients. They work by lowering the levels of LDL ... ,The drugs have also been shown to help ... disease from having a heart attack or stroke. ...
... Food and Drug Administration has found that meat or milk ... these clones—is as safe to eat as food from// conventionally ... on three documents regarding the safety of animal cloning—a draft ... guidance for industry. ,Dr. Stephen F. Sundlof, director ...
... Northern Territory's Health Department Experts have warned about the ... central Australia.// ,There have been 10 cases ... of Central Australia during the past decade, including one ... last week's torrential downpours, locals and visitors have been ...
... Bilcare, a leading research-based pharmaceutical packing solution ... with Honeywell//, a UK-based pharma packaging firm, ... pharmaceutical sector. ,"The partnership with Honeywell's ... provide state-of-the-art materials for ensuing safety of ...
Other Medicine News:Health News:'Hen Factories' To Synthesize Cancer Drugs 2Health News:Stem Cells Passed From Mother to Child Live On and Make Insulin 2Health News:Statins Aid Survival in Lung Patients, Say Experts 2Health News:FDA Finds Animal Cloned Food to Be Safe 2
(Date:12/4/2009)... Watson Pharmaceuticals, Inc. (NYSE: WPI ), ... its subsidiary, Watson Laboratories, Inc.-Florida, filed an Abbreviated New ... Administration seeking approval to market its 8mg ramelteon tablets ... Takeda Pharmaceutical Company Limited. Watson,s 8mg ramelteon tablet ...
(Date:12/4/2009)... 4 Northwest Biotherapeutics, Inc. ("NWBT" or the "Company") ... Patent and Trademark Office has allowed its patent application ... of the manufacture of the Company,s DCVax® therapeutic cancer ... the very high concentration of dendritic cells (which are ...
(Date:12/3/2009)... , a leading primary research firm, today announced the launch ... that monitors and projects trends and market share in the ... captures actual patient usage for 87 different Sleep Apnea mask ... providers going back to January 2006. In the most ...
Breaking Medicine Technology:Watson Files FDA Application for Generic Rozerem(R) 2Watson Files FDA Application for Generic Rozerem(R) 3Northwest Biotherapeutics Receives Approval of US Patent for Cost Saving Automation of High-Concentration DCVax(R) Manufacturing 2Northwest Biotherapeutics Receives Approval of US Patent for Cost Saving Automation of High-Concentration DCVax(R) Manufacturing 3Northwest Biotherapeutics Receives Approval of US Patent for Cost Saving Automation of High-Concentration DCVax(R) Manufacturing 4Northwest Biotherapeutics Receives Approval of US Patent for Cost Saving Automation of High-Concentration DCVax(R) Manufacturing 5Leading Primary Research Firm Guidepoint Global Announces Launch of Sleep Apnea Tracker 2First World Congress on Positive Psychology Kicks Off With Talks by Two of the Worlds Most Renowned Psychologists 47746 1First World Congress on Positive Psychology Kicks Off With Talks by Two of the Worlds Most Renowned Psychologists 47746 2First World Congress on Positive Psychology Kicks Off With Talks by Two of the Worlds Most Renowned Psychologists 47746 3Audi Teamed Up With Star Quarterback Tom Brady and Celebrities to Support People With Intellectual Disabilities 47742 1Audi Teamed Up With Star Quarterback Tom Brady and Celebrities to Support People With Intellectual Disabilities 47742 2Audi Teamed Up With Star Quarterback Tom Brady and Celebrities to Support People With Intellectual Disabilities 47742 3ATS Medical Announces Participation in the International Society for Minimally Invasive Cardiothoracic Surgery Meeting 47739 1ATS Medical Announces Participation in the International Society for Minimally Invasive Cardiothoracic Surgery Meeting 47739 2ATS Medical Announces Participation in the International Society for Minimally Invasive Cardiothoracic Surgery Meeting 47739 3ATS Medical Announces Participation in the International Society for Minimally Invasive Cardiothoracic Surgery Meeting 47739 4
... provider of clinical services and trial management technologies for ... along with its client Genentech, Inc as the winner ... Clinical Trial Portal solution. Winners were selected from ... panel of 14 expert judges. The ePharmaSolutions Clinical ...
... Using a steroid drug for multiple sclerosis (MS) in ... disease activity more than using the MS drug alone, according ... Program at the American Academy of Neurology,s 61st Annual Meeting ... the study, people with MS received the steroid drug methylprednisolone ...
Other Medicine Technology:ePharmaSolutions' Clinical Trial Investigator Portal Wins Bio-IT World 2009 Best Practice Award 2Adding Steroid Drug to MS Treatment May Reduce Disease Activity 2
... IEC-Innovative Endoscopy Components, LLC ... Medical Equipment "Made in ... are manufactured according to ... the most excellent design ...
... sensitive DR system. It features a 17 ... designed for most general radiographic applications. Versatile ... stand and table configurations. , ,With ... detailed patient images with reduced dose. The ...
... to provide the surgeon with an optimal work ... during cataract and retinal surgery. Perfect Pupil Injectable ... sized pupils which allows expansion of the pupil ... surgery, and allows the pupil to return to ...
... remove bone cement speedily and efficiently. , ,The ... at the point of contact, allowing it to ... of the apparatus is its ability to recognize ... the operator instantly. Probe position can thus be ...
Medicine Products: